Cheese intake lowers plasma cholesterol concentrations without increasing bile acid excretion  by Hjerpsted, Julie B. et al.
lable at ScienceDirect
Journal of Nutrition & Intermediary Metabolism 3 (2016) 12e17Contents lists avaiJournal of Nutrition & Intermediary Metabolism
journal homepage: http : / /www.jnimonl ine.com/Cheese intake lowers plasma cholesterol concentrations without
increasing bile acid excretion
Julie B. Hjerpsted, Lars O. Dragsted, Tine Tholstrup*
Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, 1958, Frederiksberg, Denmarka r t i c l e i n f o
Article history:
Received 12 January 2015
Received in revised form
19 October 2015
Accepted 9 November 2015
Available online 23 November 2015
Keywords:
Dairy
Bile acid
Cholesterol
Cardiovascular
Blood lipidsAbbreviations: CA, cholic acid; CDCA, chenodeox
cular disease; DCA, deoxycholic acid; HDCA, hyodeox
sity lipoprotein; LCA, lithocholic acid; LDL, low-
ursodeoxycholic acid.
* Corresponding author.
E-mail address: tth@life.ku.dk (T. Tholstrup).
http://dx.doi.org/10.1016/j.jnim.2015.11.002
2352-3859/© 2015 The Authors. Published by Elseviera b s t r a c t
Purpose: Cheese is a dairy product with high calcium content. It has been suggested that calcium intake
may increase fecal excretion of bile acids that would cause a regeneration of bile acids from hepatic
cholesterol and thereby result in a lowering of plasma cholesterol concentrations. We aimed to test this
hypothesis by assessing bile acid and calcium concentrations in fecal samples from humans after intake
of cheese and butter.
Methods: The study was a randomized, 2  6 weeks crossover, dietary intervention study including 23
men and women who replaced part of their habitual dietary fat intake with 13% energy from cheese or
butter.
Results: After 6 weeks of intervention cheese resulted in higher amounts of calcium excreted in feces
compared to butter. However, no difference was observed in fecal bile acid output despite lower serum
total, LDL and HDL cholesterol concentrations observed with cheese intake.
Conclusion: Wewere not able to conﬁrm the hypothesis that calcium from cheese increases the excretion
of fecal bile acids. Therefore, the mechanisms responsible for the lowering of cholesterol concentrations
with cheese compared to butter intake remains unresolved.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lately, there has been an increasing focus on cardiovascular
disease (CVD) riskwith dairy intake [1e4]. Cheese is a dairy product
with high content of saturated fat. Therefore, it has been a general
perception that cheese is associated with risk of CVD as saturated
fat is known to increase cholesterol concentrations in plasma [5,6].
However, correlations studies did not ﬁnd cheese to be related to
CVD risk [7,8] which has been supported by several prospective
studies also not ﬁnding cheese intake to be related to CVD risk
[9e11]. In addition, human intervention studies suggest that cheese
does not increase cholesterol concentrations despite the high
saturated fat content when compared to butter intake [12e14]. The
biological mechanism behind these ﬁndings has not yet been
explained.ycholic acid; CVD, cardiovas-
ycholic acid; HDL, high-den-
density lipoprotein; UDCA,
Inc. This is an open access article uIn the liver, cholesterol can undergo a series of steps to form the
primary bile acids, cholic acid (CA) and chenodeoxycholic acid
(CDCA). This pathway includes the conversion of cholesterol to 7a-
hydroxycholesterol by the enzyme, cholesterol 7a-hydroxylase as
the rate limiting step [15]. CA and CDCA are excreted mainly as
taurine and glycine conjugates via the bile duct in the small in-
testine where they are converted by bacterial 7 a-dehydroxylation
to the corresponding secondary bile acids, deoxycholic acid (DCA)
and lithocholic acid (LCA).
Calcium supplementation has been hypothesized to increase the
excretion of bile acids in feces [16e18]. The suggested reason
behind this is that calcium or calcium phosphate complexes bind to
bile acids in the intestine. The latter will cause an efﬂux of bile acids
from the enterohepatic cycle and thereby a need for regeneration of
bile acids from hepatic cholesterol. Consequently, this will result in
a lowering of cholesterol concentrations in plasma. As cheese has a
high content of calcium with a high bioavailability [19] the objec-
tive of the present study was to investigate the hypothesis that the
high calcium content may increase calcium and bile acid concen-
trations in feces and thereby decrease cholesterol concentrations in
plasma. This hypothesis was tested by assessing bile acid and cal-
cium concentrations in fecal samples from humans after intake ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2. Materials and methods
The present study is part of a larger study, described in details
elsewhere [12]. In short, 53 subjects (22e69 years of age) were
recruited for a randomized, crossover intervention, with a two-
week run-in period of habitual diet. Exclusion criteria included
current or previous CVD, diabetes mellitus or other severe chronic
disease, use of lipid-lowering agents, BMI above 32 kg/m2, and
known or suspected abuse of drugs, alcohol, or medication. Sub-
jects consumed cheese or butter for six weeks each replacing
approximately 13 energy percent (E%) of their daily fat intake. The
participants were grouped into three groups according to their
energy level and the amounts of cheese and butter to be consumed
per day were adjusted accordingly in order to substitute the 13E% of
fat: low (9.8 MJ) corresponding to 111 g cheese/37 g butter, me-
dium (9.8e12.5 MJ) corresponding to 143 g cheese/47 g butter and
high (12.5 MJ) corresponding to 176 g cheese/58 g butter. The two
intervention periods were separated by awashout period of at least
two weeks on habitual diet. The fatty acid composition of the
cheese and butter were similar [12]. Thus, the fat quality and
quantity from the cheese and butter was the same. No other dairy
products were allowed during the cheese and butter period except
from small amounts of low fat milk (0.5% fat, a maximum of 6 cl/d)
that had to be consumed throughout the intervention. There were
no dietary restrictions during the washout period. Subjects were
instructed to refrain from blood donations and dietary supplements
that might interfere with study measurements.
Twenty-three of the 53 subjects included in the intervention
agreed to hand in 2  24 h feces collections at the end of both the
cheese and butter period. A total of 23 participants agreed to deliver
the faeces samples out of the 53 subjects participating in the main
study. Baseline characteristics of these 23 subjects, included in this
study, are listed in Table 1.
In order to provide information about dietary intake during the
intervention and ensure stable weight subjects completed a 3-day
dietary record during the last two weeks of each intervention
period. Two of these days were in connection with the fecal
collection, whereas one day was the nearest weekend day to the
fecal collection which was included to take any differences in
nutrient intake during weekdays and weekends into account.
Dankost 3000 dietary assessment software (Dankost, Copenhagen,
Denmark) was used to estimate the dietary intake. The study was
approved by the Danish National Committee on Biomedical
Research Ethics.
Subjects were instructed to collect all feces excreted in pre-
weighed containers during the last two days of each intervention
period. All fecal samples were weighed when handed in. The
samples from the same day were pooled and blended with milliQ-
water (1:1) and pHwasmeasured in the homogenate. Themean pH
and fecal weight was calculated for each period. Bile acids in the
fecal samples were analyzed quantitatively. Fecal samples were
frozen at80 C until analyses by LC-MS/MS of the homogenate (a)
and the fecal water (b), as described below. A pool of all samplesTable 1
Baseline characteristics of the 23 subjects collecting fecal samples.
Mean ± SD
Men/women (no (%)) 15 (65%)/8 (35%)
Age (years) 56.7 ± 11.1
Height (cm) 173.2 ± 8.5
Body mass index (kg/m2) 25.4 ± 3.3
Smoking (no (%)) 4 (17%)was used as a calibration standard and analyzed 3 times in triplicate
together with the individual samples. The bile acids DHCA (dehy-
drocholic acid, internal standard), CDCA, UDCA, LCA and HDCA
were purchased from SigmaeAldrich (Brøndby, Denmark); CA and
DCA were purchased from Merck (Hellerup, Denmark); Bile acid
standards: 13C GCAwas purchased from SigmaeAldrich, (Brøndby,
Denmark); 13C DCA and 13C CA (internal standards) were pur-
chased from Cambridge Isotope Laboratories (Andover, USA); 13C
UDCA and LCA-d4 (internal standards) were purchased from CDN
isotopes (Quebec, Canada);
a. Internal standards consisting of a mix of 13C- labeled and
deuterated bile acids were added to 0.3 g homogenized samples
and extracted once with 60% ethanol at 60 C, then two times with
96% ethanol. The combined ethanolic supernatant was diluted by a
factor of 9 with 0.1% formic acid in water and retained on a pre-
activated Oasis HLB LP 96-well plate (Waters, Milford, Massachu-
setts, USA). After washing with 1 mL 0.1% formic acid, the bile acids
were eluted ﬁrst with 0.8 mL 50% acetonitrile with 24% methanol,
then with methanol containing 0.1% formic acid. The eluate was
evaporated to dryness and re-dissolved in a mixture of 15% aceto-
nitrile, 30% methanol, 0.1% formic acid and water. Analyses were
performed on Waters Acquity UPLC using a 5 cm BEH phenyl col-
umn and a pre-column of the same type using a gradient from
phase A to B over 5min. Themobile phases were 30%methanol and
0.1% formic acid (mobile phase A) and 100% ACN and 0.1% formic
acid (mobile phase B) at a total ﬂow rate of 0.9 mL/min. Detection
was performedwith a triple quadrupole detector (TQD) operated in
MRM mode (cone voltage, collision energy, and transitions in
brackets): CA (80,18, 407.3/ 407.3); CDCA (90, 20, 391.3/ 391.3);
DCA (70, 15, 391.3/ 391.3); hyodeoxycholic acid (HDCA) (80, 20,
391.3/ 391.3); LCA (90, 20, 375.2/ 375.2); ursodeoxycholic acid
(UDCA) (80, 18, 391.2/ 391.2); all transitions were 4Da higher for
the tetradeuterated internal standards. CV% of pooled samples was:
5.7 for CA, 4.0 for CDCA, 3.5 for DCA, 10.3 for HDCA, 6.2 for LCA, and
6.4 for UDCA. The taurine and glycine conjugates were also
analyzed using labeled standards, however concentrations in the
fecal samples were below detection limits. Standard curves were
prepared for all bile acids for quantitation and internal standards
were used to assess relative losses and ion suppression of each
analyte. The fecal bile acid concentrations from the two consecutive
collection days at the end of each intervention period were aver-
aged before the statistical analysis.
b. Bile acids in fecal water were measured to be able to calculate
percent bound bile acids in the fecal mass. Homogenized fecal
samples were centrifuged at 20,000 g for 2 h at 4 C. The aqueous
supernatant was removed and ﬁltered through Q-Max Syringe ﬁl-
ters (Membrane Cellulose Acetate, Pore size 0.20 mm, Filter dia:
25 mm, Cat. No. CA250250S, Frisenette). The samples were then
diluted with a mixture of 15% acetonitrile, 30% methanol, 0.1%
formic acid in water and analyzed on a UPLC-TQD as described for
the homogenate (a). Fecal samples from four of the 23 subjects
contained insufﬁcient amounts of fecal water for determination of
the bile acids therefore only 19 subjects are included in the results.
CV% of pooled samples for fecal water analyses were: 14.1 for CA,
14.5 for CDCA, 12.3 for DCA, 12.0 for HDCA, 28.3 for LCA and 19.1 for
UDCA. One subject had samples below the detection limit of CDCA
and two subjects had samples below the detection limit of HDCA.
Bile acid results for each subject from the two consecutive days
were averaged before the statistical analyses.
Calcium content in fecal samples collected in the ﬁrst 24 h of the
48 h collections in each dietary period was analyzed using atomic
absorption spectroscopy (Spectra AA 200 Varian, Varian Techtron
Pty. Limited, Mulgrave Victoria, Australia). Before analysis samples
were freeze dried, homogenized, and destructed (DigiPREP MS, SCP
Science, Quebec, Canada) with 67e70% HNO3 (Plasma Pure, SCP
Table 2
Average daily consumption of energy, macronutrients and calcium during the run-
in, cheese and butter period for the 23 subjects handing in fecal samples.a
Run-inb Cheese Butter
Total energy (kJ) 9312 ± 3037 9410 ± 2058 9721 ± 2431
Fat (% of energy) 31.2 ± 5.6 33.5 ± 5.7 35.5 ± 6.7
Fat (g) 77.8 ± 27.8 83.1 ± 15.2 90.5 ± 17.8
Saturated fat (g) 26.8 ± 9.8 37.0 ± 6.0 39.5 ± 6.9
Monounsaturated fat (g) 24.9 ± 11.2 26.1 ± 7.5 29.4 ± 7.6
Polyunsaturated fat (g) 12.2 ± 6.0 10.9 ± 4.7 11.5 ± 3.5
Protein (% of energy) 16.5 ± 3.4 19.2 ± 2.9** 14.0 ± 3.4
Carbohydrate (% of energy) 47.7 ± 8.1 44.8 ± 8.8* 48.3 ± 7.5
Calcium (mg) 969.1 ± 319.4 1220 ± 180** 451 ± 152
*Different from butter period (p < 0.05) (comparison between cheese and butter
period).
**Different from butter period (p < 0.0001) (comparison between cheese and butter
period).
a All values are expressed as means ± SD.
b n ¼ 22 because one subject had dietary record considered nonsufﬁcient during
this period.
Table 3
Total fecal bile acids after cheese and butter intake in men and women.a
Bile acid Cheese Butter
(mmol/24 h)
Total bile acids 272.7 ± 258.2 224.8 ± 225.8
Total primary bile acids 9.6 ± 19.1 10.5 ± 19.1
Total secondary bile acids 263.1 ± 250.2 214.3 ± 214.1
Cholic acid 4.6 ± 10.7 4.9 ± 9.7
Chenodeoxycholic acid 5.0 ± 8.5 5.6 ± 9.8
Deoxycholic acid 120.8 ± 144.0 107.4 ± 138.4
Hyodeoxycholic acid 22.5 ± 25.9 20.7 ± 24.1
Lithocholic acid 116.3 ± 88.8 83.3 ± 56.0
Ursodeoxycholic acid 3.4 ± 4.3 2.9 ± 3.0
a Values are means ± SD, n ¼ 23.
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Quebec, Canada). Samples were diluted by a solution of 0.5%
lanthanum oxide (Lanthanum(III) oxide, Merck, Darmstadt, Ger-
many) and 1% HNO3 (Plasma Pure, SCP Science, Quebec, Canada).
The calcium standard for the standard curve (1000mg Ca/L, Titrisol,
Merck, Darmstadt, Germany) was diluted by the same solution. A
reference diet (Standard Reference Material, Typical Diet 1548a,
National Institute of Standards and Technology, Gaithersburg, MD)
was analyzed together with the fecal samples. CV% of the reference
diet was 2.4. The analyses were performed in duplicates.
Fasting blood samples were taken in duplicates on consecutive
days after each intervention period. The results from all 53 partic-
ipants and the method of the blood samples analyses have been
described in details elsewhere [12]. In brief, blood samples were
collected in dry tubes and kept at room temperature for 30 min to
coagulate. Hereafter, they were centrifuged at 2200 g for 10 min at
20 C and stored at 80 C until analyzed. A standardized enzy-
matic colorimetric procedure (ABX Pentra LDL Direct CP, ref. no.
A11A01638 and HDL Direct CP, ref. no. A11A01636, Horiba ABX,
Montpellier, France) was used to measure low-density lipoprotein
(LDL) and high-density lipoprotein (HDL) cholesterol. Total
cholesterol and triacylglycerol concentrations were measured by
enzymatic procedures (Cholesterol CP, ref. no. A11A011634 and
Triglycerides CP, ref. no. A11A01640, Horiba). The analyses were
performed on an ABX Pentra 400 Chemistry Analyzer (Horiba). The
values from the two consecutive days from each intervention
period were averaged before the statistical analyses. Self-reported
compliance which was 99.8% during the butter period and 99.6%
during the cheese period. In addition, we previously reported that
feces were collected the last 2 d of each intervention period from 23
subjects and that fecal fat excretion did not differ between the
cheese and butter periods (P ¼ 0.1035).
Statistical analyses were performed using PROC MIXED in Sta-
tistical Analysis System (SAS), version 9.2 (SAS Institute, Cary, NC).
A linear mixed model incorporating systematic effects of period
and treatment and their interactionwas used to assess the effects of
treatment for all data except percent bound DCA as described
below. Age, gender, period, weight and smoking were included as
explanatory variables, if signiﬁcant, to adjust for possible differ-
ences between subjects. Non-signiﬁcant-effects were removed one
by one from the model. Subject was included as random effect to
account for the inter-subject variability. Normal probability plots
and residual plots were used to validate the model together with
statistical tests for normality (ShapiroeWilk, Kolmogor-
oveSmirnov, Cramer-von Mises and Anderson-Darling). Outcome
variables were logarithmically transformed before analysis, if
necessary. Percent bound DCA data were not normally distributed
and thereforeWilcoxon signed rank test was used for these data. All
p-values were evaluated at a 5% signiﬁcant level. Values presented
in the text are means ± SD.
3. Results
No difference was observed in weight of the feces during the
cheese and butter period (data not shown; p ¼ 0.39). Fecal pH
tended to increase with cheese intake (6.8 ± 0.5) compared to
butter intake (6.6 ± 0.5), although this was not signiﬁcantly
different (p ¼ 0.08).
Results from the 3-day dietary records (Table 2) showed that the
energy and fat intake was not signiﬁcantly different during the two
periods. The cheese period resulted in higher intakes of protein
(p < 0.0001) and lower intakes of carbohydrates (p < 0.05)
compared to the butter period. Finally, the calcium intake during
the cheese period was almost three times as high compared to the
butter period (p < 0.0001). The cheese period resulted in a 55%higher excretion of calcium in feces (955.1 ± 685.0 mg/24 h)
compared to the butter period (432.6 ± 305.8 mg/24 h) (p < 0.001).
The bile acids observed in measurable amounts in the samples
were the primary bile acids CA and CDCA and the secondary bile
acids DCA, LCA, HDCA and UDCA. No difference was observed be-
tween the two periods of cheese and butter intake regarding bile
acids excreted in the 24 h fecal collections (Table 3). Large inter-
individual and day-to-day variations were observed in the
amounts of bile acids excreted in feces for each individual whereas
the pooled calibration samples were showing limited variation.
The difference in percent of bound bile acids in fecal solids was
also not signiﬁcantly different between the two periods (Table 4).
Thus, no difference was observed in amounts or types of bile acids
when comparing the cheese and butter period. However, the
cheese period resulted in lower total-, LDL- and HDL cholesterol
concentrations in plasma compared to the butter period (p < 0.01,
p < 0.05 and p < 0.05, respectively; Table 5). There was a positive
correlation between change in Ca intake and change in bile acid
excretion between the two treatments (r2 ¼ 0.34), however, the
correlation between changes in Ca or bile acids with change in
cholesterol was weakly negative (r2 ¼ 0.09).4. Discussion
In this study the effect of cheese and butter intake on calcium
and bile acid excretion was evaluated. The amount of fat ingested
from the two dairy products was similar, however the calcium
content in these food items was highly different, which was sub-
stantiated from the dietary records. We found no difference in fecal
weight or fecal pH, although other studies suggested that fecal pH
Table 4
Percentage of bile acids bound in fecal solids after cheese and butter intake in men
and women.a
Bile acid Cheese Butter
(%/24 h)
Total bile acids 94.7 ± 2.5 94.5 ± 4.37
Total primary bile acids 75.1 ± 17.9 79.6 ± 17.4
Total secondary bile acids 95.3 ± 2.4 95.3 ± 3.8
Cholic acid 59.7 ± 21.1 66.5 ± 18.8
Chenodeoxycholic acidb 91.0 ± 6.6 87.6 ± 18.7
Deoxycholic acid 92.4 ± 3.5 89.0 ± 11.8
Hyodeoxycholic acidc 76.4 ± 15.6 82.4 ± 13.2
Lithocholic acid 99.6 ± 0.3 99.5 ± 0.5
Ursodeoxycholic acid 84.1 ± 8.9 85.3 ± 11.0
a Values are means ± SD. n ¼ 19.
b n ¼ 18 because some samples were below the detection limit.
c n ¼ 17 because some samples were below the detection limit.
Table 5
Blood lipids during the cheese and butter period for the 23men andwomen handing
in fecal samples.a
Cheese Butter
(mmol/l)
Total cholesterol 5.1 ± 0.8** 5.4 ± 0.9
LDL cholesterol 3.1 ± 0.7* 3.3 ± 0.8
HDL cholesterol 1.4 ± 0.3* 1.5 ± 0.3
Triacylglycerol 1.1 ± 0.4 1.1 ± 0.4
Statistical differences are based on linear mixed model.
*Different from butter period (p < 0.05).
**Different from butter period (p < 0.01).
a All values are expressed as means ± SD.
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cium intake from dairy products [22]. Increased pH has been sug-
gested to be associated with increased solubility of bile acids
leading to increased toxicity and colon cancer risk [23], however in
a study in adenoma patients and controls this was not substanti-
ated and no association was found between dietary intake of cal-
cium and pH [24].
The main purpose of our study was to investigate if the higher
calcium content in cheese could be responsible for a higher
excretion of calcium and bile acids in feces resulting in a lowering of
cholesterol in plasma. While calcium excretion was signiﬁcantly
elevated this did not appear to signiﬁcantly affect bile acid pre-
cipitation in feces or total bile acid excretion. Still, cheese intake
resulted in lower cholesterol concentrations compared to butter
intake.
We investigated the effect of calcium in the form of cheesewhile
others have investigated the effect of calcium as a dietary supple-
ment [20,21]. Lupton et al. reported no effect in total bile acids
output after 16 weeks of calcium supplementation in 22 subjects
with a history of resected adenocarcinoma of the colon. However,
they found the primary bile acids in dry stool to decrease with
calcium supplementation [21]. Alder et al. conducted a similar
studywhere calcium supplementation increased DCA in fecal water
compared to baseline measures [20]. In addition, they found an
increase in total bile acids and LCA in dry stool with calcium sup-
plementation compared to baseline measures. These studies had
some limitations as they compared with baseline measures instead
of e.g. placebo tablets. In addition, their focus was colon cancer and
therefore cholesterol concentrations were not measured making
the comparison with our objective difﬁcult. However, they found
some changes in bile acid concentrations with calcium supple-
mentation which suggests that calcium should be able to change
bile acid excretions. Nevertheless, calcium supplementation has
been found to lower serum total cholesterol concentrations and toincrease excretion of both total and secondary bile acids in feces
[25]. The reason for the lowering of the cholesterol concentrations
was ascribed to bile acids bindings to insoluble calcium phosphate.
Calcium supplementations may affect fecal bile acids differently
than calcium provided as a natural part of the cheese matrix. A
limited number of studies have investigated the effect of dairy
products on fecal bile acids. Govers et al. compared milk products
with high calcium content (1200 mg/d) with placebo milk products
with low calcium content (120 mg/d) in 13 males [22]. They found
the concentrations of secondary bile acids (DCA and LCA) in fecal
water to decrease with calcium intake from milk products. In
addition, they found the total amount of fecal bile acids to increase
with calcium intake supporting the hypothesis that calcium may
bind to bile acids in the intestine. More recently, Bendsen et al.
found similar results to ours, when comparing the excretion of bile
acids from a diet with high calcium content from dairy products to
a diet with low calcium content [26]. They found no differences in
total amounts of bile acids excreted but they found that the
excretion of conjugated bile acids were greater with a high calcium
diet compared with a low calcium diet. In their study, the diet high
in calcium consisted of low-fat dairy products and therefore, it
could be speculated that their result would have been different if
the diet had consisted of full-fat dairy products as in the present
study. This is of interest because increasing fat intake increases the
fecal bile acid output [27]. Results from a study taking the fat intake
into account, showed no increase in bile acid excretion with
increased dairy fat intake but an increased excretionwith increased
calcium intake from dairy [28]. Also, in that study a diet rich in
dairy calcium signiﬁcantly decreased the total- and LDL cholesterol
concentrations. Thus, the study supports the hypothesis that dairy
calcium increases fecal bile acid output and thereby decreases
cholesterol concentrations which was also suggested as a possible
mechanism by the authors. However, we were not able to support
the hypothesis that calcium from cheese increases excretion of fecal
bile acids, as results did not reach statistical signiﬁcance. Other
mechanisms responsible for the lowering of cholesterol concen-
trations with cheese intake compared to butter intake may have
been involved in the current study. A high calcium intake has also
been found to increase fecal fat excretion [22,26,28,29]. The reason
for this has been proposed to be binding of calcium to fatty acids in
the intestine resulting in the formation of insoluble soaps [30].
However, this did not appear to be a possible explanation in our
study as we found no signiﬁcant difference in fecal fat excretion
between the cheese and butter period from the same 23 subjects
included in this study [12]. The positive correlation between
change in Ca intake and change in bile acid excretion between the
two treatments (r2 ¼ 0.34) would give the impression of an effect,
however it is driven mainly by two data points and the weak cor-
relation between changes in Ca or bile acids with change in
cholesterol does not support an inverse relationship in this limited
data set. Therefore, the possible mechanisms explaining why
cheese does not increase cholesterol concentrations to the same
extent as butter (with equal amounts of fat) remains unresolved.
Other possible mechanisms explaining this effect has been
reviewed in a paper recently accepted [31]. Here it is speculated
that the high protein content of cheese, the matrix of cheese, or the
fact that cheese is a fermented product may affect cholesterol
concentrations. Also, calcium was mentioned as a possible mech-
anism, but it seems more unlikely to be a sole explanation unless
some unidentiﬁed mechanisms by which calcium can affect
cholesterol concentrations are involved.
Strength of the current study is that the full fecal collections
were homogenized before removing sample for later analysis; this
precludes that sampling errors were causing the large individual
and day-to-day ﬂuctuations observed. Use of a pooled fecal sample
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labeled internal standard for each bile acid also increases the
analytical validity of our ﬁndings. A limitation of the current study
is that a sample of fecal water should have been collected straight
after the 24 h collection. In addition, we observed large inter-
individual and day-to-day variations in the amounts of bile acids
excreted in feces whereas the repeated analyses of pooled samples
were showing limited variation, suggesting that large ﬂuctuations
in bile acid excretion rather than analytical variation decreased the
power in this study. The major limitation may have been the large
ﬂuctuations in bile acids from sample to sample in this study, even
from the same individual. This ﬂuctuation was larger than we have
seen before. Our initial comparison with other studies indicated
that we were amply powered [21], however more samples per
volunteer at the end of the study would have improved precision
and thereby power more in this study than an increase in the
number of participants. Collection of fecal samples for more than
two dayswould have resulted in better estimates of the average bile
acid loss and perhaps signiﬁcant differences in the amounts of bile
acids excreted. In regard to concentration of total bile acid levels it
is similar to those published by others [26,32], where we report
10e30% higher values. There is, however, also studies reporting
higher levels, up to 50% higher than ours [33]. Thus, we are conﬁ-
dent that we observe bile acid levels within the normal range, still
we ﬁnd no indication of total, bound or free bile acid co-variation
with dairy calcium intake in this study. However, levels of the in-
dividual bile acids vary considerably between studies and seem to
be highly matrix dependent and this is probably a major cause of
variation in total bile acid excretion. A fully controlled diet could
therefore have decreased other matrix factors thereby improving
the possibility to show a possible effect of Ca intake on bile acid
excretion.
We cannot exclude the possibility that measurement of the bile
acids at baseline could possibly have accounted for part of this
variation as individual differences in bile acid metabolism. In a
crossover design, individual differences should have minor effects
on the outcome measures so we regard this possibility as low and
the scope of the study was to compare the effects of cheese and
butter intake and therefore baseline measures of bile acids was not
assessed.
5. Conclusion
The ﬁndings of the present study do not support the hypothesis
that the high calcium content of cheese increases fecal bile acid
output. In future studies it may be advised to give a fully controlled
diet and to collect fecal samples for more than two days to further
investigate the effect of speciﬁc foods on fecal bile acid levels. The
mechanisms responsible for the lowering of cholesterol concen-
trations with cheese intake compared to butter intake remains
unresolved.
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